Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies

Simple item page
dc.contributor.authorFreites Martínez, Azael David
dc.contributor.authorSantana Rodríguez, N.
dc.contributor.authorArias Santiago, Salvador
dc.contributor.authorViera Ramírez, Agustín
dc.date.accessioned2023-03-28T18:25:40Z
dc.date.available2023-03-28T18:25:40Z
dc.date.issued2021
dc.description.filiationUEMspa
dc.description.impactNo data 2021spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationFreites-Martínez, A., Santana, N., Arias-Santiago, S., & Viera, A. (2021). Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies. Actas Dermo-Sifiliográficas (English Edition), 112(1), 90–92. https://doi.org/10.1016/j.ad.2019.05.009spa
dc.identifier.doi10.1016/j.ad.2019.05.009
dc.identifier.issn2173-5778
dc.identifier.urihttp://hdl.handle.net/11268/11967
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1016/j.ad.2019.05.009spa
dc.rights.accessRightsopen accessspa
dc.subject.otherAntineoplásicosspa
dc.subject.otherFenómenos fisiológicos de la pielspa
dc.subject.unescoCáncerspa
dc.subject.unescoTratamiento médicospa
dc.subject.unescoEfectos fisiológicosspa
dc.titleUsing the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapiesspa
dc.title.alternativeCTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicasspa
dc.typejournal articlespa
dspace.entity.typePublication

Files

Collections

Otras Áreas de Investigación de Salud